(ERIE) Erie Indemnity - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29530P1021
ERIE: Insurance, Underwriting, Sales, Customer, Administrative, IT
Erie Indemnity Company, listed on the NASDAQ under the ticker symbol ERIE, operates as a managing attorney-in-fact for the Erie Insurance Exchange. This role involves overseeing a range of critical services, including policy issuance and renewal, sales-related activities such as agent compensation, and underwriting processes. The company also provides customer service, administrative support, and IT infrastructure, making it a cornerstone of the Erie Insurance Exchanges operations.
From a financial perspective, Erie Indemnity boasts a market capitalization of $20.338 billion, with a price-to-earnings (P/E) ratio of 36.76, indicating a premium valuation relative to its earnings. The price-to-book (P/B) ratio of 10.54 suggests that investors are placing a high value on the companys assets and future prospects. With a price-to-sales (P/S) ratio of 5.51, the company is positioned as a growth-oriented play in the insurance sector.
Founded in 1925 and headquartered in Erie, Pennsylvania, Erie Indemnity has established itself as a stable player in the property and casualty insurance space. Its role as a managing attorney-in-fact for the Erie Insurance Exchange underscores its importance in facilitating the operations of one of the largest mutual insurance companies in the U.S. For investors and fund managers, Erie Indemnitys consistent profitability and dividend payments make it an attractive option for those seeking exposure to the insurance industry with a focus on stability and income generation.
The companys financial health and operational efficiency are further highlighted by its ability to maintain a competitive edge in a highly regulated industry. Its focus on underwriting excellence and customer service has allowed it to build a loyal base of policyholders, which in turn supports its revenue growth and profitability. As the insurance landscape continues to evolve, Erie Indemnitys proven business model and strong financial position make it a compelling consideration for long-term investors.
Additional Sources for ERIE Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ERIE Stock Overview
Market Cap in USD | 20,338m |
Sector | Financial Services |
Industry | Insurance Brokers |
GiC Sub-Industry | Property & Casualty Insurance |
IPO / Inception | 1995-10-02 |
ERIE Stock Ratings
Growth 5y | 73.5% |
Fundamental | 80.4% |
Dividend | 45.5% |
Rel. Strength Industry | -14.9 |
Analysts | 5/5 |
Fair Price Momentum | 365.97 USD |
Fair Price DCF | 124.67 USD |
ERIE Dividends
Dividend Yield 12m | 1.29% |
Yield on Cost 5y | 3.64% |
Annual Growth 5y | -2.74% |
Payout Consistency | 92.3% |
ERIE Growth Ratios
Growth Correlation 3m | -76.5% |
Growth Correlation 12m | 39% |
Growth Correlation 5y | 81.2% |
CAGR 5y | 21.87% |
CAGR/Max DD 5y | 0.59 |
Sharpe Ratio 12m | 0.34 |
Alpha | -1.65 |
Beta | 0.50 |
Volatility | 26.69% |
Current Volume | 114.2k |
Average Volume 20d | 204.6k |
As of February 23, 2025, the stock is trading at USD 383.46 with a total of 114,216 shares traded.
Over the past week, the price has changed by -1.41%, over one month by +0.63%, over three months by -9.48% and over the past year by +10.67%.
Yes, based on ValueRay Fundamental Analyses, Erie Indemnity (NASDAQ:ERIE) is currently (February 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 80.36 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ERIE as of February 2025 is 365.97. This means that ERIE is currently overvalued and has a potential downside of -4.56%.
Erie Indemnity has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy ERIE.
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ERIE Erie Indemnity will be worth about 421.3 in February 2026. The stock is currently trading at 383.46. This means that the stock has a potential upside of +9.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 115 | -70% |
Analysts Target Price | 115 | -70% |
ValueRay Target Price | 421.3 | 9.9% |